Table 2.
Laboratory test | Laboratory value at relapse of nephrotic syndrome | Reference range | Laboratory value at presentation for acute stroke | Reference range |
---|---|---|---|---|
Leukocyte (109/l) | 11.3 | 4.5–10.8 | 19 | 4.0–11.0 |
Hb (g/l) | 138 | 117–157 | 117 | 120–160 |
Ht (%) | 0.414 | 0.370–0.470 | 0.347 | 3.9–5.5 |
Platelet (104/mm3) | 433 | 140–400 | 369 | 145–470 |
Creatinine (μmol/l) | 57 | 53–97 | 56 | 42–89 |
Glucose (mmol/l) | 4.1 | 4.0–6.2 | ||
HbA1c | 0.0527 | 0.0440–0.0600 | ||
Albumin (g/l) | 22 | 35–52 | 13 | 36–45 |
Protein/creatinine spot ratio (g/mmol) | 1.397 | 0.828 | ||
Proteinuria (g/24 h) | 4.84 | |||
Cholesterol (mmol/l) | 9.33 | 8.25 | 3.40–7.30 | |
HDL (mmol/l) | 1.03 | 0.95 | 0.90–2.38 | |
LDL (mmol/l) | 7.2 | 5.68 | ||
Non–HDL cholesterol (mmol/l) | 8.30 | 7.30 | ||
Triglycerides (mmol/l) | 2.45 | 0.45–2.25 | 3.55 | 0.43–2.69 |
C reactive protein (mg/l) | <5.0 | <9.99 | ||
aPTT (s) | 23 | 22–31 | ||
INR | 1.0 | 0.9–1.2 | ||
Thrombin time (s) | 23 | 14–18 | ||
Fg (g/l) | 5.39 | 2.00–4.50 | ||
AT III (U/l) | 1.24 | 0.80–1.20 | ||
Functional protein C (U/l) | 1.45 | 0.70–1.40 | ||
Free protein S antigen (U/l) | 1.23 | 0.69–1.31 | ||
Homocysteine (μg/l) | 10 | <12 | ||
C3 (g/l) | 1.08 | 0.85–2.00 | ||
C4 (g/l) | 0.23 | 0.10–0.50 | ||
ANA | Negative | Negative | ||
ENA | Negative | |||
Anti-PR3 (AU) | <0.2 | 0.0–0.9 | <0.2 | 0.0–0.9 |
Antimyeloperoxidase (AU) | 7.7 | 0.0–0.9 | 2.2 | 0.0–0.9 |
Anti–glomerular basal membrane | <0.2 | <1.0 | ||
Serum anti–PLAR2 antibody | Weakly positive | |||
Factor V Leiden | Negative | |||
Mutation factor II | Negative | |||
Lupus anticoagulant | Negative | |||
Anti–cardiolipins IgM (MPL-U/ml) | 0.3 | <12.5 | ||
Anti–cardiolipin IgG (GPL-U/ml) | <1.6 | <15 |
aPTT, activated partial thromboplastin time; ANA, antinuclear antibody; AT III, antithrombin III; AU, arbitrary units; ENA, extractable nuclear antigens; Fg, fibrinogen; GPL-U, G phospholipids-unit; Hb, hemoglobin; HDL, high-density lipoprotein; Ht, hematocrite; INR, international normalized ratio; LDL, low-density lipoprotein; MPL-U, M phospholipids-unit; MPO, myeloperoxidase; PLAR2, phospholipase A2 receptor.